DaVita Inc. (DVA)
DVANYSEMisc Health and Biotechnology Services
$179.86
-5.69 (-3.06%) today
Regular session, Nov 10, 1:18 PM ET
- Market cap
- $11.31bn
- P/E
- 12.8
- EPS, last 4 quarters
- $14.11
- Dividend yield
- –
- Day range
- $178.11 to $186.09
- 52-week range
- $101.00 to $247.49
- Average volume
- 1.13m
- Previous close
- $185.54
Analysts
5 coveringHold2 buy, 2 hold, 1 sell
Targets a year out average $225.20, +25.2% from here
Earnings
next estimate $4.27Next report
Dec 2025
+4.9%
Mar 2026
+19.1%
Jun 2026
+0.3%
Sep 2026
+1.1%
estimate reported, and the surprise
Financials
| Quarter | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|
| Revenue | $3.62bn | $3.42bn | $3.55bn | $3.58bn |
| Gross profit | $1.21bn | $1.07bn | $1.16bn | $1.13bn |
| Operating income | $561.07m | $481.89m | $579.00m | $499.25m |
| Net income | $234.22m | $197.53m | $265.40m | $222.93m |
Last four quarters: revenue $14.17bn, margin 6.5%, free cash flow $1.29bn
News
8 latest- Investors Heavily Search DaVita Inc. (DVA): Here is What You Need to KnowZacks · 5 days ago
- Hormel Foods Now #495 Largest Company, Surpassing DaVita BNK Invest · 7 days ago
- DaVita (DVA) Q3 2026 Earnings Call TranscriptThe Motley Fool · Oct 30, 2026
- DaVita Q3 Earnings Beat Estimates on IKC Strength, Revenues Rise Y/YZacks · Oct 30, 2026
- What DaVita (DVA) Said on Its Q3 Earnings CallMarketBeat · Oct 30, 2026
- DaVita Inc. Reports Third Quarter 2026 Results and Updates 2026 GuidanceFintel · Oct 30, 2026
- DaVita Inc. Profit Advances In Q3 RTTNews · Oct 29, 2026
- DaVita HealthCare (DVA) Beats Q3 Earnings and Revenue EstimatesZacks · Oct 29, 2026
The company
DaVita (NYSE: DVA) is a healthcare provider focused on transforming care delivery to improve quality of life for patients globally. As a comprehensive kidney care provider, DaVita has been a leader in clinical quality and innovation for 25 years. DaVita cares for patients at every stage and setting along their kidney health journey - from slowing the progression of kidney disease to helping support transplantation. This includes ensuring they are supported at home, in dialysis centers, in the hospital and in skilled nursing facilities. As of September 30, 2026, we provided dialysis services to a total of approximately 298,100 patients at 3,269 outpatient dialysis centers, of which 2,671 centers were located in the United States and 598 centers were located in 14 countries outside of the United States.
- Sector
- Health Care
- Industry
- Misc Health and Biotechnology Services
- Exchange
- NYSE
- Region
- North America
- Website
- davita.com
Often looked at with it
Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.